Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals·        Marketing authorisation in EU expected in December ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK announced that the European Medicine Agency’s Committee for ...

Investing.com -- GSK plc (LSE:GSK) announced Tuesday that its Shingrix vaccine has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) ...

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

Combining optimized safety and security, Schreiner MediPharm's Cap-Lock plus RFID ensures product integrity while increasing ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a ...

Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...

In addition, GSK and Nasdaq-listed Spero Therapeutics Inc announced positive Pivot-PO phase III data which showed tebipenem HBr's potential as the first oral carbapenem antibiotic for patients with ...

Discover Regeneron’s Q3 2025 earnings: strong Dupixent, Libtayo & EYLEA HD growth, R&D updates, plus key manufacturing and regulatory challenges.

The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...